Literature DB >> 21247891

G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient.

Lucie P Pellissier1, Gaël Barthet, Florence Gaven, Elisabeth Cassier, Eric Trinquet, Jean-Philippe Pin, Philippe Marin, Aline Dumuis, Joël Bockaert, Jean-Louis Banères, Sylvie Claeysen.   

Abstract

The discovery that class C G protein-coupled receptors (GPCRs) function as obligatory dimeric entities has generated major interest in GPCR oligomerization. Oligomerization now appears to be a common feature among all GPCR classes. However, the functional significance of this process remains unclear because, in vitro, some monomeric GPCRs, such as rhodopsin and β(2)-adrenergic receptors, activate G proteins. By using wild type and mutant serotonin type 4 receptors (5-HT(4)Rs) (including a 5-HT(4)-RASSL) expressed in COS-7 cells as models of class A GPCRs, we show that activation of one protomer in a dimer was sufficient to stimulate G proteins. However, coupling efficiency was 2 times higher when both protomers were activated. Expression of combinations of 5-HT(4), in which both protomers were able to bind to agonists but only one could couple to G proteins, suggested that upon agonist occupancy, protomers did not independently couple to G proteins but rather that only one G protein was activated. Coupling of a single heterotrimeric G(s) protein to a receptor dimer was further confirmed in vitro, using the purified recombinant WT RASSL 5-HT(4)R obligatory heterodimer. These results, together with previous findings, demonstrate that, differently from class C GPCR dimers, class A GPCR dimers have pleiotropic activation mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21247891      PMCID: PMC3060553          DOI: 10.1074/jbc.M110.201939

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.

Authors:  Fabien M Décaillot; Raphael Rozenfeld; Achla Gupta; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

Review 3.  Dimerization in GPCR mobility and signaling.

Authors:  Martin J Lohse
Journal:  Curr Opin Pharmacol       Date:  2009-11-10       Impact factor: 5.547

4.  Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.

Authors:  Laura Albizu; Martin Cottet; Michaela Kralikova; Stoytcho Stoev; René Seyer; Isabelle Brabet; Thomas Roux; Hervé Bazin; Emmanuel Bourrier; Laurent Lamarque; Christophe Breton; Marie-Laure Rives; Amy Newman; Jonathan Javitch; Eric Trinquet; Maurice Manning; Jean-Philippe Pin; Bernard Mouillac; Thierry Durroux
Journal:  Nat Chem Biol       Date:  2010-07-11       Impact factor: 15.040

5.  Leukotriene BLT2 receptor monomers activate the G(i2) GTP-binding protein more efficiently than dimers.

Authors:  Laure Arcemisbéhère; Tuhinadri Sen; Laure Boudier; Marie-Noëlle Balestre; Gérald Gaibelet; Emilie Detouillon; Hélène Orcel; Christiane Mendre; Rita Rahmeh; Sébastien Granier; Corinne Vivès; Franck Fieschi; Marjorie Damian; Thierry Durroux; Jean-Louis Banères; Bernard Mouillac
Journal:  J Biol Chem       Date:  2009-12-21       Impact factor: 5.157

6.  Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain.

Authors:  M Riad; S Garcia; K C Watkins; N Jodoin; E Doucet; X Langlois; S el Mestikawy; M Hamon; L Descarries
Journal:  J Comp Neurol       Date:  2000-02-07       Impact factor: 3.215

7.  Dopamine D2 receptors form higher order oligomers at physiological expression levels.

Authors:  Wen Guo; Eneko Urizar; Michaela Kralikova; Juan Carlos Mobarec; Lei Shi; Marta Filizola; Jonathan A Javitch
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

8.  Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.

Authors:  Adam J Kuszak; Sethuramasundaram Pitchiaya; Jessica P Anand; Henry I Mosberg; Nils G Walter; Roger K Sunahara
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

Review 9.  Oligomerisation of G-protein-coupled receptors.

Authors:  G Milligan
Journal:  J Cell Sci       Date:  2001-04       Impact factor: 5.285

10.  Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.

Authors:  Yang Han; Irina S Moreira; Eneko Urizar; Harel Weinstein; Jonathan A Javitch
Journal:  Nat Chem Biol       Date:  2009-08-02       Impact factor: 15.040

View more
  33 in total

1.  Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers.

Authors:  Katharine Herrick-Davis; Ellinor Grinde; Tara Lindsley; Ann Cowan; Joseph E Mazurkiewicz
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

2.  Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers.

Authors:  Maxime Zoenen; Eneko Urizar; Stéphane Swillens; Gilbert Vassart; Sabine Costagliola
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

3.  Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment.

Authors:  Nabila Brabez; Ronald M Lynch; Liping Xu; Robert J Gillies; Gerard Chassaing; Solange Lavielle; Victor J Hruby
Journal:  J Med Chem       Date:  2011-10-03       Impact factor: 7.446

4.  Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells.

Authors:  Katharine Herrick-Davis; Ellinor Grinde; Tara Lindsley; Milt Teitler; Filippo Mancia; Ann Cowan; Joseph E Mazurkiewicz
Journal:  Mol Pharmacol       Date:  2015-01-21       Impact factor: 4.436

5.  Cryo-EM structure of the native rhodopsin dimer in nanodiscs.

Authors:  Dorothy Yanling Zhao; Matthias Pöge; Takefumi Morizumi; Sahil Gulati; Ned Van Eps; Jianye Zhang; Przemyslaw Miszta; Slawomir Filipek; Julia Mahamid; Jürgen M Plitzko; Wolfgang Baumeister; Oliver P Ernst; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2019-08-09       Impact factor: 5.157

6.  Multivalent ligands for the serotonin 5-HT4 receptor.

Authors:  Federica Castriconi; Marco Paolino; Alessandro Donati; Germano Giuliani; Maurizio Anzini; Laura Mennuni; Chiara Sabatini; Marco Lanza; Gianfranco Caselli; Francesco Makovec; Maria Sbraccia; Paola Molinari; Tommaso Costa; Andrea Cappelli
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

7.  Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif.

Authors:  Alexander J Frey; Salam Ibrahim; Scott Gleim; John Hwa; Emer M Smyth
Journal:  J Lipid Res       Date:  2013-03-14       Impact factor: 5.922

Review 8.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

Review 9.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

10.  The rhodopsin-transducin complex houses two distinct rhodopsin molecules.

Authors:  Beata Jastrzebska; Philippe Ringler; Krzysztof Palczewski; Andreas Engel
Journal:  J Struct Biol       Date:  2013-02-28       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.